China’s AI Chip IPO: Why Tencent’s 84% Bet Matters
As China’s last AI chip unicorn prepares for IPO, its reliance on Tencent reveals the real stakes of domestic substitution.
Markets & Investing
China's $350M Brain-Interface IPO: Who's First?
Boruikang filed for a $350M STAR Market IPO days after its sponsorship review; BrainCo quietly filed in HK. China's BCI pioneers race to be first listed.
China's AI Mania Mirrors 1929 Radio Craze, Huxiu Warns
A Chinese financial outlet draws chilling parallels between the 1929 crash and today's global AI bubble, urging investors to watch for leverage and debt risks.
Novo Nordisk Fires Back as Chinese Obesity Drug Claims Superiority
A Chinese-developed GLP-1 drug showed superior weight loss to semaglutide in a small trial, prompting a rare public rebuttal from Novo Nordisk.
The China Discount: Why the World's Most Hated Stock Market Might Be Its Biggest Bargain
Hong Kong stocks trade at a 50% discount to the S&P 500, and Q1 2026 showed the first signs of awakening. A deep dive into the math, risks, and real numbers.